Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Spector DavidDirector, Chairman & CEO |  PFSIPennyMac Financial Services, Inc.Open-market sale · 10b5-1 plan | SELL | $39K 417 sh |
| Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Rote William E.Chief Research Officer |  TVTXTravere Therapeutics, Inc.Grant or award · 10b5-1 plan | A | — 14.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Grant or award · 10b5-1 plan | A | — 14.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Murtagh Nigel JChief Risk Officer |  SCHWSCHWAB CHARLES CORPOption exercise · 10b5-1 plan | M | — 41.3K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER | TVTXTravere Therapeutics, Inc. Grant or award · 10b5-1 plan | A | — 64.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 |  Yuan Eric S.Director, Chief Executive Officer |  ZMZoom Communications, Inc.Derivative conversion · 10b5-1 plan | C | — 15.3K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 4,167 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 6,250 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner |  IRMDIRADIMED CORPOpen-market sale · 10b5-1 plan | SELL | $37K 393 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Prober Charles J.Director |  LIFLife360, Inc.Option exercise · 10b5-1 plan | M | — 7,930 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 6,250 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Grant or award · 10b5-1 plan | A | — 14.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | MLYSMineralys Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $59K 4,167 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 47 | Velaga S. RamPresident, ISG |  AVGOBroadcom Inc.Open-market sale | SELL | $2.96M 8,000 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 42 | Coen Steven P.See remarks |  DNAGinkgo Bioworks Holdings, Inc.Open-market sale | SELL | $213K 33.2K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 41 | Lingenbrink MatthewDirector |  FTLFFITLIFE BRANDS, INC.Open-market purchase | BUY | $29K 3,000 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 41 | Fitta Catherine MaryDirector |  OCCIOFS Credit Company, Inc.Open-market purchase | BUY | $6,666 2,200 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 39 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $2.17M 21.6K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 39 | Wang Chia YuanSenior Management |  GGBGERDAU S.A.Open-market sale | SELL | $105K 25.0K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 39 | Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.40M 13.8K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 36 | Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $795K 7,746 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 36 | Mehta Nikhil RameshDirector |  PUBMPubMatic, Inc.Option exercise | M | — 8,447 sh | Apr 14, 2026 traded May 31, 2025 |
| 36 | Metz MauricioExecutive Vice President |  GGGERDAU S.A.Open-market sale | SELL | $4,240 1,000 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 36 | Jain SachinChief Operating Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $760K 7,235 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 35 | Allison EricChief Product Officer |  JOBYJoby Aviation, Inc.Open-market sale | SELL | $227K 27.7K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 33 | Wheeler AshleeChief Commercial Officer |  CURVTorrid Holdings Inc.Open-market sale | SELL | $59K 30.0K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 29 | Intelligent Fanatics Capital Management LLC10% Owner |  KLNGKoil Energy Solutions, Inc.Open-market purchase | BUY | $31K 18.2K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 29 | Intelligent Fanatics Capital Management LLC10% Owner | KLNGKoil Energy Solutions, Inc. Open-market purchase | BUY | $31K 18.2K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 28 | Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $507K 5,097 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 27 | McNemar KarenFormer CFO |  ITOXIIOT-OXYS, Inc.Other acquisition or disposition | J | — 6,045 sh | Apr 14, 2026 traded Nov 5, 2025 |
| 27 | Emmons Clifford LDirector, CEO | ITOXIIOT-OXYS, Inc. Other acquisition or disposition | J | — 269 sh | Apr 14, 2026 traded Nov 5, 2025 |
| 27 | McNemar KarenFormer CFO | ITOXIIOT-OXYS, Inc. Other acquisition or disposition | J | — 269 sh | Apr 14, 2026 traded Nov 5, 2025 |